YDES · YD Bio Ltd · Metrics
Market Cap
$422.86M
Shares
70.83M
Volume · Nov 6
207.61K
Avg daily vol (3M)
305.48K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
YDES metrics
64 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$5.97
Market cap
$422.86M
Price action
23 metricsPrice change (1W)
+22.3%
Price change (30D)
+22.1%
Price change (3M)
+203.7%
Price change (6M)
+35.7%
Price change (YTD)
-41.1%
Price change (1Y)
-31.9%
Trailing year
Price change (5Y)
—
52-week high
$15.42
52-week low
$1.90
Change from 52-week high
-53.4%
Change from 52-week low
+277.9%
Annualized volatility
135.3%
Annualized volatility (3M)
189.6%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
0.0
RSI (14D)
61.4
Price vs SMA 50
+35.8%
Price vs SMA 200
+32.4%
Avg volume (3M)
302,594
Relative volume
0.3
Average dollar volume
$1.42M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
70.83M
Valuation
12 metricsP / E (TTM)
1,663.3
Trailing earnings · reciprocal yield 0.1%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
410.4×
reciprocal yield 0.2%
P / book
113.7
reciprocal yield 0.9%
FCF yield
-1.7%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
0.1%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
29.6%
Operating margin
-528.7%
Trailing 12 months
Net margin
24.7%
Gross profit (TTM)
$366,845
Operating profit (TTM)
−$6.55M
Net income (TTM)
$305,762
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
-702.2%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+16.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1.24M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.1%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
6.8%
Return on assets
3.0%
Debt / equity
—
Current ratio
5.2
EBITDA (TTM)
—
Free cash flow (TTM)
−$8.70M
Quick ratio
3.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$2.66M
Total assets
$10.06M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$7.26M
Capital expenditures (TTM)
$1.45M
R&D (TTM)
$1.92M
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
155.3%
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
13
13F filer change QoQ
+5
Institutional ownership
0.4%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+123.6%
Holder tenure
2.7
Price vs estimated holder cost
-78.7%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.0%
Short interest
3 metricsShort interest
0.3%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
45 / 100
Insider activity
2 metricsNet insider buying (90D)
$128,525
Insider-sentiment score
81 / 100
Risk flags
1 metricsGoing concern
—